Characterization of a novel CD2+ human thymic B cell subset

Area of Science:

• Immunology
• Developmental Biology

Background:

• The presence and function of B cells within the human thymus during fetal development are not fully understood.
• Identifying specific B cell subsets and their functional capabilities in the fetal thymus is crucial for understanding immune system development.

Purpose of the Study:

• To investigate the presence and characteristics of functionally mature B cells in the human fetal thymus.
• To determine if thymic B cells express CD2 and if this marker is associated with a mature phenotype and function.

Main Methods:

• Flow cytometry was used to analyze cell surface markers (CD19, CD2, CD20, CD40, CD34, surface IgM) on fetal and postnatal thymic B cells.
• In vitro culture experiments were performed to assess immunoglobulin (Ig) isotype switching and Ig secretion in response to various stimuli, including IL-4, activated CD4+ T cells, anti-CD40 mAb, and anti-CD2 mAb.

Main Results:

• A significant population of CD19+ B cells co-expressing CD2 (46 +/- 7%) was found in the fetal and postnatal human thymus.
• These CD2+ thymic B cells exhibited a mature phenotype (CD20+, CD40+, surface IgM+) but lacked CD34 expression.
• Purified thymic B cells demonstrated functional maturity, undergoing Ig isotype switching and differentiation into Ig-secreting cells in vitro, comparable to conventional B cells.

Conclusions:

• Functionally mature B cells are present in the human thymus early in fetal life.
• Thymic CD2+ B cells represent a distinct subset of bona fide B cells capable of Ig isotype switching and production.
• These findings contribute to our understanding of B cell development and immune system maturation in the thymus.